FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ascend Laboratories Tamsulosin Hydrochloride Capsules Recall

Tamsulosin Hydrochloride Capsules, USP, 0

Ascend Laboratories LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Mar 13, 2019
Recall ID
D-1066-2019
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Tamsulosin Hydrochloride Capsules starting Feb 22, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1066-2019 on Mar 13, 2019. Reason: Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.

Product description

Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.

Lot numbers, UPCs & expiration codes

Lot #: 8144652, Exp Jul 2020

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1066-2019
Classification
Class II
Status
Terminated
Recall initiated
Feb 22, 2019
FDA report date
Mar 13, 2019
Quantity
3,072 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-1066-2019, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
82223
Address
339 Jefferson Rd Ste 101
Code information
Lot #: 8144652, Exp Jul 2020
Postal code
07054-3707
Report date
Mar 13, 2019
Product type
Drugs
Recall number
D-1066-2019
Classification
Class II
Recalling firm
Ascend Laboratories LLC
Product quantity
3,072 bottles
Termination date
Mar 18, 2020
Reason for recall
Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Feb 22, 2019
Initial firm notification
Letter
Center classification date
Mar 29, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1066-2019, published Mar 13, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls